2007
DOI: 10.1001/archneur.64.12.1771
|View full text |Cite
|
Sign up to set email alerts
|

α7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease

Abstract: Background: Dysfunction of basocortical cholinergic projection neurons of the nucleus basalis (NB) correlates with cognitive deficits in Alzheimer disease (AD). Nucleus basalis neurons receive cholinergic inputs and express nicotinic acetylcholine receptors (nAChRs) and muscarinic AChRs (mAChRs), which may regulate NB neuron activity in AD. Although alterations in these AChRs occur in the AD cortex, there is little information detailing whether defects in nAChR and mAChR gene expression occur in cholinergic NB… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
91
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 98 publications
(101 citation statements)
references
References 44 publications
8
91
0
Order By: Relevance
“…In addition, a7 nAChR expression was increased by approximately 50% in both AD/GAL-and AD/GAL+ cells relative to NCI cells ( fig. 1 b), similar to previous observations in mild/moderate AD [14] .…”
Section: Resultssupporting
confidence: 92%
“…In addition, a7 nAChR expression was increased by approximately 50% in both AD/GAL-and AD/GAL+ cells relative to NCI cells ( fig. 1 b), similar to previous observations in mild/moderate AD [14] .…”
Section: Resultssupporting
confidence: 92%
“…Increased intracellular Ca 2ϩ can lead to cell death and has been associated with neuronal death in neurodegenerative diseases (35). Along these lines, overexpression of ␣7-nAChRs has been shown to play a role in neurological disorders (36). Studies have shown that in neuronal cultures, gp120 can induce an increase in Ca 2ϩ levels, leading to neuronal injury, an effect that can be blocked with memantine (37).…”
Section: Discussionmentioning
confidence: 99%
“…Appropriate caution must however be maintained, because false positives might be generated when evaluating protein expression using commercially available antibodies (Herber et al, 2004;Jones and Wonnacott, 2005). Experiments conducted with competitive antagonists such as a-Btx or MLA have found opposing results: an increase in expression of a7 nAChRs thought to compensate for the loss of ACh in AD (Counts et al, 2007;Liu et al, 2013) and reduced expression of a7 nAChRs in other studies (Burghaus et al, 2000). A lower level of a7 nAChR expression on neurons, at the same time as expression was higher on astrocytes, was also reported in sporadic and familial AD (Yu et al, 2005).…”
Section: A Alzheimer's Diseasementioning
confidence: 99%